Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-18

FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA has approved a supplemental application for ropinirole filed by Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)